evofosfamide

Ligand id: 8695

Name: evofosfamide

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 10
Topological polar surface area 121.13
Molecular weight 446.93
XLogP 1.5
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
IUPAC Name
2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine
International Nonproprietary Names
INN number INN
9811 evofosfamide
Synonyms
compound 3b [2] | TH-302
Database Links
CAS Registry No. 918633-87-1 (source: PubChem)
ChEMBL Ligand CHEMBL260046
PubChem CID 11984561
Search Google for chemical match using the InChIKey UGJWRPJDTDGERK-UHFFFAOYSA-N
Search Google for chemicals with the same backbone UGJWRPJDTDGERK
Search PubMed clinical trials evofosfamide
Search PubMed titles evofosfamide
Search PubMed titles/abstracts evofosfamide
Search UniChem for chemical match using the InChIKey UGJWRPJDTDGERK-UHFFFAOYSA-N
Search UniChem for chemicals with the same backbone UGJWRPJDTDGERK
Comments
Evofosfamide is a hypoxia-activated prodrug being investigated as an antineoplastic therapeutic (compound 3b in [2]). This compound is related to ifosfamide. Being developed by Threshold Pharmaceuticals.